Why the study?
Do serum glutamic oxalacetic transaminase levels rise and correlate with infarct size after experimental myocardial infarction in dogs?
Population
Closed chest dog model of myocardial infarction produced by bead embolization of the coronary tree
Comparison
Measurement of serum glutamic oxalacetic… vs Normal baseline levels
Design
Preclinical
Follow-up
up to autopsy
Authors
Loading...
May aid experimental infarct assessment in dogs; leaves open translation to human diagnostics.
Do serum glutamic oxalacetic transaminase levels rise and correlate with infarct size after experimental myocardial infarction in dogs?
Serum transaminase levels rise significantly after experimental myocardial infarction and correlate with infarct size, suggesting utility as a diagnostic and quantitative clinical tool.
Agress et al. (1955) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: